Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by medvic1on Feb 11, 2020 4:31pm

96 Views

Post# 30676593

RE:RE:RE:All phase lll studies require a DSMB

... and it is a bit strange, many don't realise how important DSMB "''Go ahead" ticket mean for the study. Stock and study are valid, this things are going to be Big. Many years ago I was in the same situation with CVM at 0.31c, (now it's $14+ at Ph3 study). Now, SVA gives "Watch" signal, stock price will be up and up. Good luck to longs.